Plasma lysozyme as surrogate biomarker for detection of coronary artery disease in patients without Standard Modifiable Cardiovascular Risk Factors (SMuRFless)

1 September 2025 (13:15 - 14:00)
Organised by: Logo
Add to my library
Congress Presentation Part of: Pathophysiology of ischaemic heart disease Non-Invasive Diagnostic Methods ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology